Cargando…

Discovery and characterization of potent And‐1 inhibitors for cancer treatment

Acidic nucleoplasmic DNA‐binding protein 1 (And‐1), an important factor for deoxyribonucleic acid (DNA) replication and repair, is overexpressed in many types of cancer but not in normal tissues. Although multiple independent studies have elucidated And‐1 as a promising target gene for cancer therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jing, Zhang, Yi, Sun, Jing, Chen, Leyuan, Gou, Wenfeng, Chen, Chi‐Wei, Zhou, Yuan, Li, Zhuqing, Chan, David W., Huang, Ruili, Pei, Huadong, Zheng, Wei, Li, Yiliang, Xia, Menghang, Zhu, Wenge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684776/ https://www.ncbi.nlm.nih.gov/pubmed/34923765 http://dx.doi.org/10.1002/ctm2.627

Ejemplares similares

Identification of potent SENP1 inhibitors that inactivate SENP1/JAK2/STAT signaling pathway and overcome platinum drug resistance in ovarian cancer
por: Zhang, Yi, et al.
Publicado: (2021)

Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo
por: Li, Zhong, et al.
Publicado: (2020)

Discovery and Characterization of the Biflavones From Ginkgo biloba as Highly Specific and Potent Inhibitors Against Human Carboxylesterase 2
por: Song, Yun-Qing, et al.
Publicado: (2021)

The deubiquitylating enzyme USP15 regulates homologous recombination repair and cancer cell response to PARP inhibitors
por: Peng, Yihan, et al.
Publicado: (2019)

Discovery of triterpenoids as potent dual inhibitors of pancreatic lipase and human carboxylesterase 1
por: Zhang, Jing, et al.
Publicado: (2022)

And‐1 O‐GlcNAcylation regulates homologous recombination repair and radioresistance in colorectal cancer
por: Zhou, Yuan, et al.
Publicado: (2022)

SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistance
por: Li, Jing, et al.
Publicado: (2021)

Discovery and characterization of naturally occurring potent inhibitors of catechol-O-methyltransferase from herbal medicines
por: Zhao, Dong-Fang, et al.
Publicado: (2021)

Discovery of a Potent, Covalent BTK Inhibitor for B-Cell Lymphoma
por: Wu, Hong, et al.
Publicado: (2014)

Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode
por: Hu, Chen, et al.
Publicado: (2017)

Identification of Angiogenesis Inhibitors Using a Co-culture Cell Model in a High-Content and High-Throughput Screening Platform
por: Li, Shuaizhang, et al.
Publicado: (2017)

Discovery and characterization of a novel potent type II native and mutant BCR-ABL inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML)
por: Liu, Feiyang, et al.
Publicado: (2016)

Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors
por: Fang, Feifei, et al.
Publicado: (2023)

Discovery of novel KRAS‒PDEδ inhibitors with potent activity in patient-derived human pancreatic tumor xenograft models
por: Chen, Long, et al.
Publicado: (2022)

Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor
por: Lal, Shruti, et al.
Publicado: (2023)

Discovery of Uracil Derivatives as Potent Inhibitors of Fatty Acid Amide Hydrolase
por: Qiu, Yan, et al.
Publicado: (2016)

Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor
por: Li, Yueshan, et al.
Publicado: (2022)

In vivo quantitative high-throughput screening for drug discovery and comparative toxicology
por: Dranchak, Patricia K., et al.
Publicado: (2023)

Design and synthesis of benzodiazepines as brain penetrating PARP-1 inhibitors
por: Yu, Jiang, et al.
Publicado: (2022)

Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
por: Zheng, Mengzhu, et al.
Publicado: (2017)

QSAR Accelerated Discovery of Potent Ice Recrystallization Inhibitors
por: Briard, Jennie G., et al.
Publicado: (2016)

Discovery of Dimeric Arylsulfonamides as Potent ADAM8 Inhibitors
por: Cuffaro, Doretta, et al.
Publicado: (2021)

Use of Tox21 Screening Data to Evaluate the COVID-19 Drug Candidates for Their Potential Toxic Effects and Related Pathways
por: Sakamuru, Srilatha, et al.
Publicado: (2022)

Discovery of Potent EGFR Inhibitors With 6-Arylureido-4-anilinoquinazoline Derivatives
por: Li, Meng, et al.
Publicado: (2021)

Virtual Screening and Structure-Based Discovery of Indole Acylguanidines as Potent β-secretase (BACE1) Inhibitors
por: Zou, Yiquan, et al.
Publicado: (2013)

Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies
por: Mei, Husheng, et al.
Publicado: (2023)

Discovery and Characterization of a Potent and Selective Inhibitor of Aedes aegypti Inward Rectifier Potassium Channels
por: Raphemot, Rene, et al.
Publicado: (2014)

Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout
por: Tan, Philip K., et al.
Publicado: (2017)

Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury
por: Xia, Kaijiang, et al.
Publicado: (2020)

Discovery of 2-(4-Acrylamidophenyl)-Quinoline-4-Carboxylic Acid Derivatives as Potent SIRT3 Inhibitors
por: Hui, Qian, et al.
Publicado: (2022)

Discovery of highly potent SARS-CoV-2 M(pro) inhibitors based on benzoisothiazolone scaffold
por: Chen, Weixiong, et al.
Publicado: (2022)

Repurposing drugs as COVID-19 therapies: A toxicity evaluation
por: Ngan, Deborah K., et al.
Publicado: (2022)

Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors
por: Chen, Yiming, et al.
Publicado: (2021)

MON-032 Identification of Estrogen-Related Receptor Alpha Inhibitors from the Tox21 10K Compound Collection
por: Lynch, Caitlin, et al.
Publicado: (2019)

Discovery of Potent and Specific Dihydroisoxazole Inhibitors of Human Transglutaminase 2
por: Klöck, Cornelius, et al.
Publicado: (2014)

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent Vasodilators
por: Tripathi, Neetika, et al.
Publicado: (2018)

Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps
por: Fan, Wenli, et al.
Publicado: (2021)

Discovery of Natural Products as Novel and Potent FXR Antagonists by Virtual Screening
por: Diao, Yanyan, et al.
Publicado: (2018)

Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors
por: Brotherton-Pleiss, Christine, et al.
Publicado: (2020)

Oxoisoaporphine as Potent Telomerase Inhibitor
por: Wei, Zu-Zhuang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vjh31a0e8i6jg1blqjkmqmsr1s